Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Escherichia coli ACN001 - : ciprofloxacin [CFS] |
👶
Biogenic Synthesis and Characterization of Chitosan-CuO Nanocomposite and Evaluation of Antibacterial Activity against Gram-Positive and -Negative Bacteria. Polymers (Polymers (Basel) ) Vol: 14 Issue 9 Pages: Pub: 2022 Apr 29 Epub: 2022 Apr 29 Authors Umoren PS , Kavaz D , Nzila A , Sankaran SS , Umoren SA , Html Article Publication |
| Decreases Escherichia coli ACN001 - : ciprofloxacin [CFS] |
👶
Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 43 Issue 3 Pages: 525-9 Pub: 1999 Mar Epub: Authors Kamberi M , Tsutsumi K , Kotegawa T , Kawano K , Nakamura K , Niki Y , Nakano S , Html Article Publication |
| Decreases Escherichia coli ACN001 - : ciprofloxacin [CFS] |
👶
Vitex Negundo-Fe(3)O(4)-CuO green nanocatalyst (VN-Fe(3)O(4)-CuO): synthesis of pyrazolo[3,4-c]pyrazole derivatives via the cyclization of isoniazid with pyrazole and their antimicrobial activity, cytotoxicity, and molecular docking studies. RSC advances (RSC Adv ) Vol: 14 Issue 1 Pages: 677-688 Pub: 2024 Jan 2 Epub: 2024 Jan 2 Authors Akbar I , Mullaivendhan J , Ahamed A , Aljawdah HM , Html Article Publication |
| Decreases Escherichia coli ACN001 - : ciprofloxacin [CFS] |
👶
Antibiotic Efficacy in Escherichia coli and Klebsiella pneumoniae Under Nutrient Limitation and Effectiveness of Colistin-Based Antibiotic Combinations to Eradicate Persister Cells. Current microbiology (Curr Microbiol ) Vol: 81 Issue 1 Pages: 34 Pub: 2023 Dec 8 Epub: 2023 Dec 8 Authors Seo J , Na IY , Ko KS , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
